Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-043996 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,089
Total Value
$31,686.90
P&L
+1.0% (+$301.78)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Sep 21, 2026 | Purchase | 9,771 | $2.10 | $20,519.10 | 2,850,000 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Sep 23, 2026 | Purchase | 5,318 | $2.10 | $11,167.80 | 2,855,318 | Indirect | By Opaleye, L.P. | View Details |